Forensic Toxicology

As per available reports about 82 journals, 154 Conferences, 32 workshops are presently dedicated exclusively to forensic toxicology and about 3,66284 articles are being published on the current trends in forensic toxicology. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to forensic toxicology are being carried out. As reported in “Echocardiography a Non-Invasive Method for Investigating Preclinical Drug Toxicity and Safety” article, Echocardiography (EC) is a method used for investigating cardiac morphology and function. Two-dimensional EC gives a visualization of the morphology of the heart. M-mode EC allows heart function to be monitored.
Pulsed Doppler EC is the method of choice for measuring blood flows through valves and large vessels. EC is used in routine in clinic and veterinary practice but is infrequently applied to preclinical evaluation of drug toxicity and safety pharmacology despite a number of advantages. Since similar investigations can be done in laboratory animals and humans, preclinical and clinical findings can easily be transposed to each other. EC is totally non-invasive, it does not induce any suffering to the animals and has no impact on health and physiology. It allows repeated measurements and consequently monitoring of development and evolution of adverse effects.
In this way, EC evaluates the functional adverse effects of drugs on the cardiovascular system and the consequences of induced lesions. Moreover, using the different modes of EC it is possible to determine the changes in heart contractility and hemodynamics that are involved in the development of cardiovascular lesions. This is illustrated by an experiment in dogs treated with minoxidil. The development of lesions in the right atrium and left ventricle were considered to be related to changes in the function of these cardiac structures as demonstrated by EC recordings. These findings confirm the usefulness of EC in assessing the pathogenesis of drug-related cardiac toxicity.

The Journal of Clinical Toxicology (JCT) is a Scholarly Open Access journal that deals with the toxic effects of agents (drugs) whose purpose is to ameliorate or prevent a disease. The journal addresses both scientific research and clinical advances in clinical toxicology. This free journal provides an open access platform for researcher’s work in clinical toxicology in hospitals, academia, government or industrial sectors. This Scientific journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.
Journal of Clinical Toxicology aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

Journal of Clinical Toxicology is supporting 6^th International Summit on Toxicology & Applied Pharmacology which is going to be held during October 27-29, 2016, in Rome, Italy with the respective theme “New Challenges and Innovations in Pharmacological and Toxicological Sciences”.